Nath Bio-Genes Financials

NSE: NATHBIOGEN | BSE: 537291

₹153.12

up-down-arrow0.05 (0.03%)

As on 04-Sep-2026 15:52IST

Market cap

info icon

₹290 Cr

Revenue (TTM)

info icon

₹490 Cr

P/E Ratio

info icon

7.9

P/B Ratio

info icon

0.4

Div. Yield

info icon

1.3 %

Income Statement (₹ Cr)

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08
Operating Revenue
489.81
364.91
332.62
301.36
278.36
137.70
Total Income
497.75
369.45
333.25
301.92
280.22
138.28
Total Expenditure
440.50
314.95
282.67
252.38
241.14
117.80
EBITDA
49.31
49.96
49.96
48.98
37.22
19.90
Depreciation
3.99
3.82
3.26
3.01
3.08
4.51
EBIT
45.31
46.15
46.69
45.97
34.14
15.39
Interest
17.06
10.65
9.20
10.36
10.64
3.67
Other Income
7.95
4.55
0.63
0.55
1.85
0.58
Exceptional Items
5.14
0.54
3.45
--
-88.78
--
Profit before Tax
41.35
40.58
41.56
36.16
-63.43
12.30
Provision for Tax
4.74
1.98
1.95
1.15
3.95
0.55
Profit after Tax
36.61
38.60
39.62
35.01
-67.39
11.75
Minority Interest
--
--
--
--
--
--
Share of Associate
--
--
--
0.02
0.00
--
Consolidated Profit
36.61
38.60
39.62
35.03
-67.38
11.75

Liabilities (₹ Cr)

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08
Shareholder's Funds
680.46
644.39
609.92
573.17
541.93
57.47
Minority Interest
--
--
--
--
0.00
--
Non-Current Liabilities
22.27
16.52
7.87
3.19
3.28
1.79
Current Liabilities
394.70
365.30
262.45
216.43
194.29
98.12
Total Liabilities
1,097.42
1,026.21
880.23
792.80
739.49
158.28

Assets (₹ Cr)

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08
Non-Current Assets
275.92
336.20
308.57
272.97
271.72
37.63
Current Assets
778.86
690.01
571.66
519.83
467.77
119.75
Total Assets
1,097.42
1,026.21
880.23
792.80
739.49
158.28
Total Debt*
--
122.50
110.35
105.21
92.96
19.25
Net Current Assets
384.17
324.71
309.22
303.40
273.48
21.63
Contingent Liabilities
--
89.31
92.40
71.85
60.59
0.34

Cashflow (₹ Cr)

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08
Cash From Operating Activities
--
17.58
74.59
38.37
17.05
14.21
Cash Flow from Investing Activities
--
-3.96
-27.40
-2.88
-19.85
-20.77
Cash from Financing Activities
--
-2.13
-7.78
-1.67
-22.23
5.74
Net Cash Inflow / Outflow
--
11.49
39.41
33.81
-25.04
-0.81

Financials Ratios

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08
Adjusted EPS (₹) info
17.74
20.31
20.85
18.43
-35.46
--
Cash EPS (₹) info
19.26
22.32
22.56
20.01
-33.84
10.16
Adjusted Book Value (₹) info
375.04
339.08
320.94
301.61
285.16
--
Dividend per Share (₹) info
1.31
2.00
2.00
2.00
2.00
--
Cash Flow per Share (₹) info
--
9.25
39.25
20.19
8.97
8.88
Free Cash Flow per Share (₹) info
--
-0.24
20.63
13.50
-44.38
-6.76

Profitability Ratios

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08
ROCE (%) info
--
6.89
7.26
7.09
-14.84
23.88
ROE (%) info
4.96
6.15
6.70
6.28
-22.48
22.76
ROA (%) info
3.45
4.05
4.74
4.57
-15.03
8.50
EBIT Margin (%) info
9.25
12.65
14.04
15.25
12.26
11.18
Net Margin (%) info
7.36
10.45
11.89
11.60
-24.05
8.49
Cash Profit Margin (%) info
--
11.62
12.89
12.62
-23.10
11.80

Growth Ratios

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08
Revenue Growth (%) info
21.02
9.71
10.37
8.26
102.15
11.13
EBIT Growth (%) info
17.44
-1.17
1.58
34.66
--
54.30
Net Profit Growth (%) info
18.02
-2.57
13.16
151.96
-673.70
27.66
EPS Growth (%) info
23.02
-2.57
13.11
151.98
-583.10
--
Book Value Growth (%) info
--
5.65
6.41
5.77
842.91
25.69

Valuation Ratios

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08
Price / Earnings info
7.92
7.18
8.33
7.69
--
--
Price / Book Value info
0.41
0.43
0.54
0.47
0.75
--
Dividend Yield (%) info
1.31
1.37
1.15
1.41
0.94
--
EV/EBITDA info
6.16
5.70
7.18
6.79
12.65
1.60
Close Price (₹) info
164.77
145.85
174.05
141.25
213.35
--
High Price (₹) info
238.69
264.50
244.60
261.90
474.70
--
Low Price (₹) info
126.15
137.55
139.05
128.30
191.85
--
Market Cap (₹ Cr) info
289.91
277.18
330.20
269.30
405.46
--

Solvency Ratios

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08
Debt to Equity info
0.03
0.19
0.18
0.18
0.17
0.33
Short term debt to equity ratio info
--
0.17
0.17
0.18
0.17
0.30
Current Ratio info
1.97
1.89
2.18
2.40
2.41
1.22
Quick Ratio info
0.83
0.96
1.30
1.44
1.27
0.43
Interest Coverage info
3.42
4.81
5.52
4.49
-4.96
4.35

Operating Efficiency Ratios

TTM Mar-25 Mar-24 Mar-23 Mar-22 Mar-13 Mar-12 Mar-11 Mar-10 Mar-09 Mar-08
Debtors to sales (%) info
17.44
24.36
28.35
32.29
30.73
15.24
Asset Turnover info
0.46
0.38
0.40
0.39
0.62
1.00
Receivable days info
--
91.63
105.14
110.74
69.85
44.32
Inventory Days info
--
284.23
240.40
259.30
195.06
189.43
Payable days info
--
-249.00
-1,457.17
744.29
1,503.38
-4,219.16
Cash Conversion Cycle info
--
624.86
1,802.71
-374.25
-1,238.47
4,452.91
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...